PF-06761281
SIGMA/PZ0318 - ≥97% (HPLC)
Synonym: (2R)
CAS Number: 1854061-19-0
Empirical Formula (Hill Notation): C13H17NO6
Molecular Weight: 283.28
MDL Number: MFCD30187578
Linear Formula: C13H17NO6
Product Type: Chemical
| assay | ≥97% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C13H17NO6/c1-8-5-9(11( |
| InChI key | FGYMJXFSHBLHLW-CYBMUJFWSA |
| Quality Level | 100 ![]() |
| shipped in | dry ice |
| SMILES string | CC1=CC(CC[C@](CC(O)=O)(O) |
| solubility | H2O: 20 mg/mL, clear |
| storage temp. | −20°C |
| Application: | PF-06761281 has been used as a SLC13A family inhibitor, in rats to determine its unbound partition coefficient (Kpuu), to estimate its potency as a drug. |
| Biochem/physiol Actions: | PF-06761281 is an inhibitor of the sodium-coupled citrate transporter (NaCT or SLC13A5), which may be a target for tretment and prevention of metabolic disorders. The SLC13 transporters SLC13A2 (NaDC1), SLC13A3 (NaDC3), and SLC13A5 (NaCT) co-transport di- and tricarboxylates with multiple sodium ions into cells. PF-06761281 inhibits citrate uptake with an IC50 of 740 nM for NaCT in human hepatocytes. PF-06761281 has >25-fold in vitro selectivity for NaCT over NaDC1 and NaDC3 and was inactive in a selectivity panel of 65 targets. |
| General description: | PF-06761281 is a small, polar dicarboxylate compound. Its structure is similar to citrate, which is the endogenous substrate of Na+-citrate cotransporter (NaCT). It is a novel, potent inhibitor of SLC13a2/3/5 (solute channel) family, along with selectivity for NaCT. |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS06 |
| Signal word | Danger |
| Hazard statements | H301 |
| Precautionary statements | P301 + P330 + P331 + P310 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥97% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12161503 |


